22.06.2010 • NewsGasPioneer Natural Resourcesportfolio

Reliance to Pay $1.35 Billion for Pioneer Field Stake

India's Reliance Industries, building its presence in the U.S. shale gas industry, was close to announcing a deal to pay $1.35 billion for a stake in a field controlled by Pioneer Natural Resources, the Financial Times reported, citing people familiar with the matter.

Reliance, India's largest listed company, will buy a 45% stake in the Eagle Ford shale gas field in south Texas, the people said, according to the newspaper. The deal would be the second of its kind in recent months for Reliance, which is controlled by the world's fourth-richest man, Mukesh Ambani.

In April, his energy-based conglomerate agreed to pay $1.7 billion to Atlas Energy to form a joint venture and own a 40% stake in Atlas' Marcellus Shale operations in the eastern U.S. A Reliance official declined to comment when reached by Reuters on Tuesday.

Ambani said last week Reliance was looking to build up its presence in the U.S. shale gas business. Reliance is also making a push into the power and telecoms sectors now that it is no longer constrained by a pact that forbade it from competing in industries where Ambani's long-estranged brother, Anil Ambani, is also present.

Earlier this month, two sources familiar with the matter told Reuters that Reliance was in talks to buy a stake in Pioneer's shale gas assets, and was also in talks with several other firms to acquire similar assets. Reliance was represented by Barclays and UBS, while Pioneer was advised by Bank of America Merrill Lynch, the Financial Times reported.

The newspaper said on its website that the deal would be announced after the close of business in New York on Tuesday.

(6/22/2010)

Virtual Event

Digitalization in the Chemical Industry
CHEManager Spotlight

Digitalization in the Chemical Industry

Save the Date: October 22, 2025
The event will be promoted to a combined audience of over 100,000 professionals across Europe through the CHEManager and CITplus networks.

Free Virtual Event

Vaccine Manufacturing
Bioprocess Forum

Vaccine Manufacturing

Join global experts and innovators for a two-day virtual event exploring the latest breakthroughs and best practices in vaccine manufacturing. Discover how new technologies and process innovations are shaping the future of vaccine production, safety, and scalability.

most read

Photo
13.03.2025 • News

Roche and Zealand Pharma Collaborate on Weight Management Drug

Swiss pharma heavyweight Roche announced has entered into an exclusive collaboration and licensing agreement with Denmark’s Zealand Pharma. Under the terms of this agreement, the two companies will collaborate to co-develop and co-commercialize petrelintide, Zealand Pharma’s amylin analog as a standalone therapy as well as a fixed-dose combination with Roche’s lead incretin asset CT-388.